Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma adiponectin decrease in women with nonalcoholic Fatty liver.

Miyao Matsubara1

  • 1Division of Endocrinology and Metabolism, Otaru City General Hospital, Wakamatsu 1-2-1, Otaru 047-8550, Japan.

Endocrine Journal
|January 13, 2005
PubMed
Summary

Low adiponectin levels (hypoadiponectinemia) are observed in women with nonalcoholic fatty liver (NAFL). This reduction in adiponectin may contribute to fat accumulation in the liver, a condition linked to metabolic syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationships between plasma adiponectin and blood cells, hepatopancreatic enzymes in women.

Thrombosis and haemostasis·2004
Same author

Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation.

European journal of endocrinology·2003
Same author

Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios.

European journal of endocrinology·2003
Same author

Elevated serum leptin concentrations in women with hyperuricemia.

Journal of atherosclerosis and thrombosis·2002
Same author

Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women.

European journal of endocrinology·2002
Same author

Decreased plasma adiponectin concentrations in women with dyslipidemia.

The Journal of clinical endocrinology and metabolism·2002

Area of Science:

  • Endocrinology
  • Hepatology
  • Metabolic Syndrome Research

Background:

  • Adiponectin, an adipocyte-secreted hormone, plays a crucial role in metabolic regulation.
  • Nonalcoholic fatty liver (NAFL) disease is frequently associated with metabolic syndrome components.
  • Altered adiponectin levels are implicated in various metabolic disorders.

Purpose of the Study:

  • To investigate plasma adiponectin concentrations in women diagnosed with nonalcoholic fatty liver (NAFL).
  • To explore the relationship between adiponectin levels and metabolic syndrome variables in NAFL patients.

Main Methods:

  • Study included 36 women with NAFL and 64 control women.
  • NAFL diagnosis based on ultrasound, elevated ALT, and exclusion of alcohol/other liver diseases.

Related Experiment Videos

  • Plasma adiponectin, leptin, hepatic enzymes, and metabolic syndrome parameters were measured.

    • Main Results:

    • NAFL women exhibited increased metabolic syndrome variables, hepatic enzymes, and leptin compared to controls.
    • A significant reduction in adiponectin was observed in NAFL women, both before and after adjusting for body fat mass.
    • Lower adiponectin levels correlated with increased insulin resistance (HOMA-R) and atherogenic index.

    Conclusions:

    • Hypoadiponectinemia is present in women with nonalcoholic fatty liver (NAFL).
    • Reduced adiponectin levels may be a contributing factor to hepatic fat accumulation in NAFL.
    • Adiponectin levels are a potential biomarker for NAFL and associated metabolic dysfunction.